Home / CJC-1295 (no DAC)
CJC-1295 (no DAC)
CJC-1295 (no DAC) is a GHRH analogue. A modified fragment of growth hormone releasing hormone. The no-DAC form lacks the drug affinity complex, giving a short pulse rather than sustained elevation.
Reference only. This page covers what the compound is, how it is presented and how it is handled. It does not give dosing protocols or administration schedules, and it is not medical advice.
Class and mechanism
CJC-1295 (no DAC) is a GHRH analogue. A modified fragment of growth hormone releasing hormone. The no-DAC form lacks the drug affinity complex, giving a short pulse rather than sustained elevation.
How it is supplied
CJC-1295 (no DAC) is supplied as a lyophilised powder or pre-filled pen, alone or blended with Ipamorelin. Reported half-life: Approximately 30 minutes for the no-DAC form. The DAC version extends this to several days. Storage: 2-8 C, protected from light.
| Listing | Strength | Price | Cost per mg | Stock |
|---|---|---|---|---|
| Quanta Pharma CJC-1295 (Without DAC) | - | £33 | - | in stock |
| SerenQ Ipamorelin + CJC 1295 (No Dac) Peptide Pen | - | £55 | - | in stock |
Stocked at The PED Shop
Quanta Pharma CJC-1295 (Without DAC)in stock£33- SerenQ Ipamorelin + CJC 1295 (No Dac) Peptide Penin stock£55
Availability checked 2026-09-08. The product page carries live stock.